Sheffield, SouthYorkshire

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease2 trials

Phase

• Phase 32 trials

Status

• Withdrawn2 trials

Lead sponsor

• Karuna Therapeutics, Inc., a Bristol Myers Squibb company2 trials

Closed trials

• Recruiting

  A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)

  NCT06126224· Phase 3· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Source

• Recruiting

  Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

  NCT05980949· Phase 3· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Source